834 Urine based bladder cancer detection by an electronic nose system: First results of a pilot study

2015 ◽  
Vol 14 (2) ◽  
pp. e834 ◽  
Author(s):  
M. Horstmann ◽  
D. Steinbach ◽  
C. Fischer ◽  
A. Enkelmann ◽  
M-O. Grimm ◽  
...  
2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Marcus Horstmann ◽  
Daniel Steinbach ◽  
Claudia Fischer ◽  
Astrid Enkelmann ◽  
Marc-Oliver Grimm ◽  
...  

2021 ◽  
Vol 5 (1) ◽  
pp. 22
Author(s):  
Heena Tyagi ◽  
Emma Daulton ◽  
Ayman S. Bannaga ◽  
Ramesh P. Arasaradnam ◽  
James A. Covington

This study outlines the use of an electronic nose as a method for the detection of VOCs as biomarkers of bladder cancer. Here, an AlphaMOS FOX 4000 electronic nose was used for the analysis of urine samples from 15 bladder cancer and 41 non-cancerous patients. The FOX 4000 consists of 18 MOS sensors that were used to differentiate the two groups. The results obtained were analysed using s MultiSens Analyzer and RStudio. The results showed a high separation with sensitivity and specificity of 0.93 and 0.88, respectively, using a Sparse Logistic Regression and 0.93 and 0.76 using a Random Forest classifier. We conclude that the electronic nose shows potential for discriminating bladder cancer from non-cancer subjects using urine samples.


2020 ◽  
Vol 28 (1) ◽  
pp. 33-39 ◽  
Author(s):  
Kazumasa Matsumoto ◽  
Yasukiyo Murakami ◽  
Yuriko Shimizu ◽  
Takahiro Hirayama ◽  
Wataru Ishikawa ◽  
...  

2021 ◽  
Vol 32 ◽  
pp. P26
Author(s):  
L. Di Gianfrancesco ◽  
M. Foti ◽  
M. Ragonese ◽  
G. Palermo ◽  
E. Sacco ◽  
...  

2018 ◽  
Vol 17 (2) ◽  
pp. e1427
Author(s):  
H. Heers ◽  
J.M. Gut ◽  
A. Hegele ◽  
R. Hofmann ◽  
T. Boeselt ◽  
...  

2021 ◽  
Vol 10 (21) ◽  
pp. 4984
Author(s):  
PierFrancesco Bassi ◽  
Luca Di Gianfrancesco ◽  
Luigi Salmaso ◽  
Mauro Ragonese ◽  
Giuseppe Palermo ◽  
...  

Background: Bladder cancer (BCa) emits specific volatile organic compounds (VOCs) in the urine headspace that can be detected by an electronic nose. The diagnostic performance of an electronic nose in detecting BCa was investigated in a pilot study. Methods: A prospective, single-center, controlled, non-randomized, phase 2 study was carried out on 198 consecutive subjects (102 with proven BCa, 96 controls). Urine samples were evaluated with an electronic nose provided with 32 volatile gas analyzer sensors. The tests were repeated at least two times per sample. Accuracy, sensitivity, specificity, and variability were evaluated using mainly the non-parametric combination method, permutation tests, and discriminant analysis classification. Results: Statistically significant differences between BCa patients and controls were reported by 28 (87.5%) of the 32 sensors. The overall discriminatory power, sensitivity, and specificity were 78.8%, 74.1%, and 76%, respectively; 13/96 (13.5%) controls and 29/102 (28.4%) BCa patients were misclassified as false positive and false negative, respectively. Where the most efficient sensors were selected, the sensitivity and specificity increased up to 91.1% (72.5–100) and 89.1% (81–95.8), respectively. None of the tumor characteristics represented independent predictors of device responsiveness. Conclusions: The electronic nose might represent a potentially reliable, quick, accurate, and cost-effective tool for non-invasive BCa diagnosis.


2020 ◽  
Vol 19 ◽  
pp. e79
Author(s):  
P.F. Bassi ◽  
L. Di Gianfrancesco ◽  
M. Ragonese ◽  
E. Sacco ◽  
G. Palermo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document